Sale of shares by a Director
The Board of EKF Diagnostics Holdings plc (AIM: EKF) has been informed that on 20 April 2021 Christopher Mills, Chairman, sold a total of 3,963,591 ordinary shares of 1 pence each in the Company (“Ordinary Shares”) at an average price of 80 pence per Ordinary Share.
Following this transaction, Christopher Mills' total direct and indirect interest in the Group is 132,150,000 Ordinary Shares representing approximately 29.04% of the Group's total issued share capital.
The Notification of Dealing Form required in accordance with UK MAR is set out below.
Enquiries:
|
EKF Diagnostics Holdings plc |
www.ekfdiagnostics.com Tel: 00 44 29 2071 0570 |
|
N+1 Singer (Nomad & Broker) Aubrey Powell / George Tzimas (Corporate Finance) Tom Salvesen (Corporate Broking) |
Tel: 020 7496 3000 |
|
Walbrook PR Limited |
Tel: 020 7933 8780 or Mob: 07980 541 893 / 07584 391 303 |
About EKF Diagnostics Holdings plc
EKF is a leading point-of-care diagnostics and central laboratory assay manufacturer with an estimated 80,000 hemoglobin, hematocrit, HbA1c, glucose and lactate analysers in regular use across more than 100 countries. EKF specialises in developing tests for use in anemia and diabetes diagnosis and management, as well as providing a portfolio of reagents for use in clinical chemistry analysers.
EKF specialises in the development, production and worldwide distribution of point-of-care analyzers and clinical chemistry reagents for use in hospital and research laboratories, doctor's offices, blood banks and for in-field anaemia screening programmes. EKF is also a bulk manufacturer of enzymes and has custom manufacturing facilities in the USA for a variety of life science products.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||
|
a)
|
Name
|
Christopher Mills
|
|||
|
2
|
Reason for the notification
|
||||
|
a)
|
Position/status
|
Non-Executive Chairman |
|||
|
b)
|
Initial notification /Amendment
|
Initial Notification |
|||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
|
a)
|
Name
|
EKF Diagnostics Holdings plc |
|||
|
b)
|
LEI
|
213800DXTF3EAUK1AR05
|
|||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||
|
a)
|
Description of the financial instrument, type of instrument |
Ordinary shares of £0.01 each |
|||
|
|
|
||||
|
Identification code |
GB0031509804
|
||||
|
|
|
||||
|
b)
|
Nature of the transaction
|
Sale of shares |
|||
|
c)
|
Price(s) and volume(s) |
|
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
|
|
|
|
0.80 |
3,963,591 |
|
|
|
|
|
|
|
|
|
|
d)
|
Aggregated information |
|
|||
|
|
|
||||
|
- Aggregated volume |
N/A – Single Transaction |
||||
|
|
|
||||
|
- Price |
|
||||
|
|
|
||||
|
e)
|
Date of the transaction |
20 April 2021 |
|||
|
f)
|
Place of the transaction |
London Stock Exchange |
|||
Newsletter
Keep up to date with all our activities, events, exhibitions, promotions, investor news & more.